Group One Trading’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.28M Sell
36,300
-14,800
-29% -$1.03M ﹤0.01% 1951
2025
Q4
$3.39M Sell
51,100
-11,900
-19% -$769K 0.01% 1827
2025
Q3
$4.24M Buy
63,000
+2,300
+4% +$182K 0.01% 1621
2025
Q2
$5.3M Buy
60,700
+13,700
+29% +$1.07M 0.01% 1288
2025
Q1
$3.21M Sell
47,000
-9,200
-16% -$751K 0.01% 1420
2024
Q4
$4.37M Buy
56,200
+25,300
+82% +$1.87M 0.01% 1268
2024
Q3
$2.07M Buy
30,900
+13,100
+74% +$1.08M 0.01% 1687
2024
Q2
$2.02M Buy
17,800
+1,000
+6% +$126K 0.01% 1448
2024
Q1
$2.33M Sell
16,800
-48,600
-74% -$6.11M 0.01% 1377
2023
Q4
$8.12M Buy
65,400
+2,500
+4% +$255K 0.02% 819
2023
Q3
$5.87M Buy
62,900
+3,300
+6% +$372K 0.02% 846
2023
Q2
$7.66M Buy
59,600
+10,000
+20% +$1.21M 0.02% 674
2023
Q1
$5.76M Sell
49,600
-170,400
-77% -$19.1M 0.02% 769
2022
Q4
$24.9M Buy
220,000
+9,000
+4% +$988K 0.06% 327
2022
Q3
$17M Buy
211,000
+32,000
+18% +$2.71M 0.03% 461
2022
Q2
$13.3M Sell
179,000
-35,400
-17% -$3.23M 0.02% 675
2022
Q1
$27.4M Sell
214,400
-390,800
-65% -$42.7M 0.03% 466
2021
Q4
$81.2M Buy
605,200
+168,400
+39% +$24.2M 0.07% 201
2021
Q3
$59.7M Sell
436,800
-187,200
-30% -$23.6M 0.06% 240
2021
Q2
$66.6M Buy
624,000
+175,200
+39% +$16.8M 0.08% 187
2021
Q1
$40.3M Sell
448,800
-57,600
-11% -$5.41M 0.06% 286
2020
Q4
$46.8M Buy
506,400
+455,600
+897% +$40.7M 0.08% 201
2020
Q3
$5.24M Sell
50,800
-3,200
-6% -$334K 0.02% 890
2020
Q2
$5.47M Sell
54,000
-8,800
-14% -$787K 0.03% 750
2020
Q1
$4.23M Buy
62,800
+42,400
+208% +$2.64M 0.03% 622
2019
Q4
$1.12M Buy
20,400
+6,000
+42% +$285K 0.01% 1783
2019
Q3
$537K Buy
14,400
+1,200
+9% +$46.6K ﹤0.01% 2274
2019
Q2
$494K Sell
13,200
-26,400
-67% -$830K ﹤0.01% 2142
2019
Q1
$1.18M Buy
39,600
+31,600
+395% +$1.11M 0.01% 1293
2018
Q4
$240K Sell
8,000
-7,200
-47% -$228K ﹤0.01% 2538
2018
Q3
$544K Sell
15,200
-7,200
-32% -$223K ﹤0.01% 2208
2018
Q2
$532K Buy
22,400
+20,800
+1,300% +$441K ﹤0.01% 2232
2018
Q1
$30K Buy
1,600
+1,200
+300% +$17.7K ﹤0.01% 3910
2017
Q4
$6K Sell
400
-299,200
-100% -$3.89M ﹤0.01% 4510
2017
Q3
$3.66M Buy
299,600
+291,600
+3,645% +$5.15M 0.03% 663
2017
Q2
$146K Sell
8,000
-21,200
-73% -$392K ﹤0.01% 2868
2017
Q1
$619K Sell
29,200
-2,000
-6% -$39K 0.01% 1698
2016
Q4
$466K Sell
31,200
-58,400
-65% -$1.03M ﹤0.01% 1826
2016
Q3
$1.96M Buy
89,600
+84,800
+1,767% +$1.89M 0.02% 863
2016
Q2
$95K Buy
+4,800
New +$81.7K ﹤0.01% 2899
2016
Q1
Sell
-80,400
Closed -$1.65M 4641
2015
Q4
$1.65M Buy
80,400
+28,800
+56% +$599K 0.02% 991
2015
Q3
$1.11M Buy
51,600
+2,000
+4% +$44.6K 0.02% 1170
2015
Q2
$992K Buy
49,600
+29,600
+148% +$520K 0.01% 1213
2015
Q1
$312K Sell
20,000
-63,200
-76% -$955K ﹤0.01% 2002
2014
Q4
$1.15M Buy
83,200
+41,200
+98% +$504K 0.02% 997
2014
Q3
$420K Sell
42,000
-82,800
-66% -$846K 0.01% 1756
2014
Q2
$1.24M Buy
124,800
+104,800
+524% +$929K 0.02% 993
2014
Q1
$207K Buy
20,000
+12,000
+150% +$124K ﹤0.01% 2415
2013
Q4
$71K Buy
+8,000
New +$63.3K ﹤0.01% 3327

Other funds holding DXCM

Group One Trading's DXCM Position: Q1 2026 in Review

Group One Trading reduced its DexCom (DXCM) stake by 94% in Q1 2026, selling an estimated $1.92M and leaving 1,706 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #4659.

Group One Trading first reported a position in DXCM in Q4 2013 and has held it in 34 quarters since. The position peaked at $17.3M in Q4 2020. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Group One Trading held 1,706 shares of DexCom worth $107K as of Q1 2026.
  • Group One Trading sold 27,571 DexCom shares in Q1 2026, an estimated $1.92M.
  • DexCom made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4659 holding.
  • Group One Trading first reported a position in DexCom in Q4 2013 and has held it in 34 quarters since.
  • Group One Trading's DexCom position peaked at $17.3M in Q4 2020.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.